All Viruses articles – Page 49
-
NewsGut microbiota may hold the secret to reaching 100
Researchers studying centenarians have discovered that the combination of intestinal bacteria and bacterial viruses of these people is quite unique.
-
NewsCats can play a role in family transmission of COVID-19
Cats can play a role in the transmission of SARS-CoV-2 and their contaminated environment can be infectious, according to new research.
-
NewsFlu virus hacks iron transport system to break into our cells
Scientists have discovered how the influenza A virus hijacks the mechanism for importing iron into cells to invade its host.
-
NewsTest tube immune system IDs protein candidates for HIV vaccine
Scientists have developed a technique to find protein fragments that best stimulate the immune system to recognize and attack the virus.
-
FeaturesThe climate crisis and the spread of vector-borne disease
The effects of climate change could see future global outbreaks caused by mosquito-borne arboviruses expand their current geographical spread.
-
NewsDeadly virus structures pinpoint new targets for Lassa vaccine design
By comparing the structures of protein complexes from different lineages of the dangerous Lassa virus, a research team has identified new antibodies and vaccine targets.
-
CareersUnearthing the secrets of living rocks
Working on a NASA-CSA project was a dream come true - and 13 years on, I’ve travelled the world unravelling the secret of contemporary microbialites.
-
NewsKissing down the epochs played role in disease transmission
Romantic kissing was a common practice in ancient times and cannot be regarded as a sudden biological trigger causing a spread of specific pathogens, a new study suggests.
-
OpinionThe threat of viral zoonosis hasn’t gone away
Why we’re liable to be ambushed by viral zoonosis - despite everything we’ve learned from Covid
-
NewsCovid beta variant in Mozambique transmitted through regional migration
A genomic surveillance study in Mozambique reveals that the beta variant of the virus was transmitted through regional migration, and questions the benefits of closing borders.
-
NewsMonkeypox virus remains stable on surfaces for days
Researchers warn that it is extremely important to disinfect surfaces to decrease the risk of monkeypox in the event of an outbreak.
-
NewsEngineered virus with immunotherapy safe and improves cancer outcomes
A new study validates the safety of a combination approach using an engineered virus and immunotherapy to target an aggressive brain cancer, and offers promise to adapt treatment strategies.
-
NewsClinical trial of mRNA universal influenza vaccine candidate begins
A clinical trial of an experimental universal influenza vaccine, H1ssF-3928 mRNA-LNP, has begun enrolling volunteers to test for safety and its ability to induce an immune response.
-
NewsFilamentous phage structure mapped for the first time
Researchers have mapped out what a commonly-used form of phage looks like, which will help researchers design better uses in future.
-
FeaturesA new frontier in Zika vaccine development
A milestone achievement for science in combating the Zika virus as a new vaccine trial begins in the UK.
-
NewsAncestral mitoviruses discovered in mycorrhizal fungi
A new group of mitochondrial viruses confined to the arbuscular mycorrhizal fungi Glomeromycotina may represent an ancestral lineage of mitoviruses.
-
NewsPostal HPV kits boost cervical screening uptake
At-home high-risk human papillomavirus (hrHPV) sampling kits can help increase cervical cancer screening among under-screened women from low-income backgrounds, according to findings from a US-based clinical trial.
-
NewsMeet Ginger: the gene-edited calf resistant to BVDV
Scientists introduce Ginger, the first gene-edited calf with reduced susceptibility to a major viral pathogen.
-
NewsProtein may pave way to eliminating HIV latency
Researchers have identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor that shuts down viral protein production and helps virus-infected cells to escape from anti-HIV therapy and immune responses.
-
NewsCRISPR-based drug candidate targets the microbiome
Scientists have engineered the first published CRISPR-based candidate for a drug - a combination of phages - that targets E. coli directly and leaves the microbiome intact.